Regulatory positioning and Research Use boundaries.
AXIONOVA operates under a dual-jurisdiction strategy: United States FDA primary commercial pathway and Mexico COFEPRIS home base. This statement describes jurisdictional planning and operational governance. It does not state or imply that any AXIONOVA compound, device, software module, HALO workflow, protocol structure, or AI output has received FDA approval, FDA clearance, COFEPRIS authorization, or therapeutic-use authorization unless AXIONOVA publishes a specific written regulatory status statement for that item.
AXIONOVA uses two distinct intelligence layers. ALETHRA is the active governance layer behind identity, verification, authorization, protocol compliance, chain-of-custody, cartridge records, and device event logs across compounds, AXIS, SENSE, and partner access. ALETHA is the active AXIONOVA AI agent for coaching, protocol personalization, diet programming, guided education, practitioner support, and 24/7 user assistance. Governance and intelligence operate together. ALETHRA governs the system. ALETHA guides the experience.
Public materials are Research Use Only.
AXIONOVA public materials are Research Use Only. Compounds, protocol structures, stack logic, device workflows, biometric intelligence outputs, and public education materials are not represented as treatments, cures, diagnostic tools, disease-prevention products, emergency services, or substitutes for licensed clinical judgment. Professional use, telehealth oversight, imports, exports, distribution, advertising, privacy, data protection, and emergency-response workflows must be reviewed under the applicable legal and regulatory framework before implementation.
U.S. FDA primary commercial pathway · Mexico COFEPRIS home base. This jurisdiction statement does not imply FDA approval, COFEPRIS authorization, product clearance, device clearance, or therapeutic authorization.
Review the boundaries that govern access.
Access to AXIONOVA materials and workflows is governed through documented oversight and Research Use Only boundaries. Review the Research Disclaimer and Terms of Use, or request review through Clinical Access.